Alidad Mireskandari
CIK: 0002030509
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NIKI
Niki BioSolutions, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Mireskandari Alidad
Mireskandari Alidad (SEC CIK 0002030509) files insider reports with the SEC as President, & COO of Niki BioSolutions, Inc. (NIKI).
Signal8 holds 1 ownership filing by Mireskandari Alidad, a Form 3, filed on Jul 28, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Mireskandari Alidad's filings is in PRINCETON, NJ.
Other insiders filing for Niki BioSolutions, Inc. (NIKI)
- Philips Laura A, Director
- Sheinerman Kira, Director
- Arner Douglas Wayne, Director
- Wu Justin Che Yuen, Director